Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Zhongguo Zhong Yao Za Zhi ; 44(15): 3305-3311, 2019 Aug.
Artigo em Zh | MEDLINE | ID: mdl-31602887

RESUMO

To enhance in vitro dissolution of Cur by preparing Cur solid dispersions. The ability of HPMCAS-HF,HPMCAS-MF,HPMCAS-LF and PVPK30 to maintain supersaturated solution was investigated by supersaturation test. Amorphous solid dispersions were prepared by the solvent-evaporation method. The prepared samples were characterized using infrared spectroscopy( IR) and differential scanning calorimetry( DSC),and in vitro dissolution was investigated. DSC and IR results showed that in 1 ∶3 and 1 ∶9 solid dispersions,Cur was amorphously dispersed in the carrier,and the interaction existed between drug and carrier. The supersaturation test showed that the order of the ability of polymer to inhibit crystallization of Cur was MF>HF>LF>K30. The dissolution results showed that Cur-K30 amorphous solid dispersion had the highest drug release rate; Cur-K30 and Cur-LF amorphous solid dispersions had a quicker but not stable dissolution rate,and the drug concentration decrease after 4 h; Cur-MF and Cur-HF solid dispersions had a low dissolution,which however increased steadily,attributing to the strong ability of the polymers to inhibit the crystallization of Cur. HPMCAS could inhibit the degradation of Cur better than K30,especially MF and HF. The amorphous solid dispersions of cur significantly enhanced the dissolution of Cur and improved the chemical stability of Cur. This study can provide a basis for the rational selection of the polymer used for Cur solid dispersion.


Assuntos
Curcumina/química , Metilcelulose/análogos & derivados , Química Farmacêutica , Estabilidade de Medicamentos , Metilcelulose/química , Polímeros , Solubilidade
2.
Guang Pu Xue Yu Guang Pu Fen Xi ; 33(10): 2629-32, 2013 Oct.
Artigo em Zh | MEDLINE | ID: mdl-24409705

RESUMO

A molecularly imprinted polymers (MIPs) of Ractopamine (RCT) was prepared by thermal polymerization method, and the adsorptive characters of the MIPs was investigated with ultraviolet spectrophotometric method. The results showed that RCT had the maximum absorbance value at the wavelength of 272 nm, the regression equation of RCT was y = 7.354 1x + 0.001 0, R2 = 0.999 9, and the average adsorption rate of MIPs was 83.4%. According to the adsorption kinetics, the adsorption time should be controlled within 10 minutes. Infrared spectrum analysis indicated that the MIPs was formed by hydrogen bonds between RCT and functional monomer methacrylic acid, the MIPs of RCT recognized RCT and combined with it exclusively via hydrogen bonds. The investigation is very useful and important for establishing RCT detection methods based on molecularly imprinted technology.


Assuntos
Impressão Molecular , Fenetilaminas/análise , Polímeros , Adsorção , Ligação de Hidrogênio , Metacrilatos , Espectrofotometria Ultravioleta
3.
Eur Radiol ; 22(11): 2328-37, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22653284

RESUMO

OBJECTIVE: To investigate the feasibility of highly efficient and controllable stem cell labelling for cellular MRI. METHODS: A new class of cationic, superparamagnetic iron oxide nanoparticle (SPION)-loaded nanovesicles was synthesised to label rat bone marrow mesenchymal stem cells without secondary transfection agents. The optimal labelling conditions and controllability were assessed, and the effect of labelling on cell viability, proliferation activity and multilineage differentiation was determined. In 18 rats, focal ischaemic cerebral injury was induced and the rats randomly injected with 1 × 10(6) cells labelled with 0-, 8- or 20-mV nanovesicles (n = 6 each). In vivo MRI was performed to follow grafted cells in contralateral striata, and results were correlated with histology. RESULTS: Optimal cell labelling conditions involved a concentration of 3.15 µg Fe/mL nanovesicles with 20-mV positive charge and 1-h incubation time. Labelling efficiency showed linear change with an increase in the electric potentials of nanovesicles. Labelling did not affect cell viability, proliferation activity or multilineage differentiation capacity. The distribution and migration of labelled cells could be detected by MRI. Histology confirmed that grafted cells retained the label and remained viable. CONCLUSION: Stem cells can be effectively and safely labelled with cationic, SPION-loaded nanovesicles in a controllable way for cellular MRI. KEY POINTS: • Stem cells can be effectively labelled with cationic, SPION-loaded nanovesicles. • Labelling did not affect cell viability, proliferation or differentiation. • Cellular uptake of SPION could be controlled using cationic nanovesicles. • Labelled cells could migrate along the corpus callosum towards cerebral infarction. • The grafted, labelled cells retained the label and remained viable.


Assuntos
Compostos Férricos/química , Imageamento por Ressonância Magnética/métodos , Nanopartículas/química , Animais , Lesões Encefálicas/patologia , Isquemia Encefálica/patologia , Cátions , Proliferação de Células , Sobrevivência Celular , Infarto Cerebral/patologia , Magnetismo , Masculino , Nanopartículas Metálicas/química , Microscopia Eletrônica de Transmissão/métodos , Nanotecnologia/métodos , Polietilenoglicóis/química , Ácido Poliglutâmico/química , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
4.
J Huazhong Univ Sci Technolog Med Sci ; 35(5): 707-711, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26489626

RESUMO

Gabexate mesilate (GM) is a trypsin inhibitor, and mainly used for treatment of various acute pancreatitis, including traumatic pancreatitis (TP), edematous pancreatitis, and acute necrotizing pancreatitis. However, due to the characteristics of pharmacokinetics, the clinical application of GM still needs frequently intravenous administration to keep the blood drug concentration, which is difficult to manage. Specially, when the blood supply of pancreas is directly damaged, intravenous administration is difficult to exert the optimum therapy effect. To address it, a novel thermosensitive in-situ gel of gabexate mesilate (GMTI) was developed, and the optimum formulation of GMTI containing 20.6% (w/w) P-407 and 5.79% (w/w) P188 with different concentrations of GM was used as a gelling solvent. The effective drug concentration on trypsin inhibition was examined after treatment with different concentrations of GMTI in vitro, and GM served as a positive control. The security of GMTI was evaluated by hematoxylin-eosin (HE) staining, and its curative effect on grade II pancreas injury was also evaluated by testing amylase (AMS), C-reactive protein (CRP) and trypsinogen activation peptide (TAP), and pathological analysis of the pancreas. The trypsin activity was slightly inhibited at 1.0 and 5.0 mg/mL in GM group and GMTI group, respectively (P<0.05 vs. P-407), and completely inhibited at 10.0 and 20.0 mg/mL (P<0.01 vs. P-407). After local injection of 10 mg/mL GMTI to rat leg muscular tissue, muscle fiber texture was normal, and there were no obvious red blood cells and infiltration of inflammatory cells. Furthermore, the expression of AMS, CRP and TAP was significantly increased in TP group as compared with control group (P<0.01), and significantly decreased in GM group as compared with TP group (P<0.01), and also slightly inhibited after 1.0 and 5.0 mg/mL GMTI treatment as compared with TP group (P<0.05), and significantly inhibited after 10.0 and 20.0 mg/mL GMTI treatment as compared with TP group (P<0.01). HE staining results demonstrated that pancreas cells were uniformly distributed in control group, and they were loosely arranged, partially dissolved, with deeply stained nuclei in TP group. Expectedly, after gradient GMTI treatment, pancreas cells were gradually restored to tight distribution, with slightly stained nuclei. This preliminary study indicated that GMTI could effectively inhibit pancreatic enzymes, and alleviate the severity of trauma-induced pancreatitis, and had a potential drug developing and clinic application value.


Assuntos
Preparações de Ação Retardada/farmacologia , Gabexato/farmacologia , Pancreatite/tratamento farmacológico , Inibidores de Serina Proteinase/farmacologia , Ferimentos Penetrantes/tratamento farmacológico , Amilases/metabolismo , Animais , Proteína C-Reativa/metabolismo , Preparações de Ação Retardada/síntese química , Preparações de Ação Retardada/farmacocinética , Gabexato/química , Gabexato/farmacocinética , Géis , Masculino , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/enzimologia , Oligopeptídeos/metabolismo , Pâncreas/efeitos dos fármacos , Pâncreas/enzimologia , Pâncreas/patologia , Pancreatite/enzimologia , Pancreatite/etiologia , Pancreatite/patologia , Poloxâmero/química , Ratos , Ratos Sprague-Dawley , Inibidores de Serina Proteinase/química , Inibidores de Serina Proteinase/farmacocinética , Temperatura , Ferimentos Penetrantes/complicações , Ferimentos Penetrantes/enzimologia , Ferimentos Penetrantes/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA